Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2

Nanotoxicology

Volumn 11, Issue 4, 2017, Pages 443-453

  Kreyling, Wolfgang G ^a   Holzwarth, Uwe ^b   Schleh, Carsten ^a   Kozempel, Ján ^b   Wenk, Alexander ^a   Haberl, Nadine ^a   Hirn, Stephanie ^a   Schäffler, Martin ^a   Lipka, Jens ^a   Semmler Behnke, Manuela ^a   Gibson, Neil ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

accumulation in secondary organs and tissues; different biokinetics pattern after gavage versus intravenous injection; gavage; gut absorption; Size selected, radiolabeled titanium dioxide nanoparticles

Indexed keywords

TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; VANADIUM; VANADIUM 48; NANOPARTICLE; POLLUTANT; RADIOISOTOPE; TITANIUM; TITANIUM DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; FEMALE; GLOMERULUS FILTRATION; INTESTINE EPITHELIUM; ISOTOPE LABELING; KIDNEY; LIVER; LUNG; NANOTOXICOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOMETRY; RAT; RETENTION TIME; SKELETON; SOFT TISSUE; SPLEEN; TOXICOKINETICS; URINARY EXCRETION; UTERUS; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; CHEMISTRY; DOSE RESPONSE; FECES; GASTROINTESTINAL TRACT; METABOLIC CLEARANCE RATE; METABOLISM; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHARMACOKINETICS; POLLUTANT; SURFACE PROPERTY; TIME FACTOR; TISSUE DISTRIBUTION; URINE; WISTAR KYOTO RAT;

ADMINISTRATION, ORAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FECES; FEMALE; GASTROINTESTINAL TRACT; METABOLIC CLEARANCE RATE; NANOPARTICLES; PARTICLE SIZE; RADIOISOTOPES; RATS; RATS, INBRED WKY; SURFACE PROPERTIES; TIME FACTORS; TISSUE DISTRIBUTION; TITANIUM; VANADIUM;

EID: 85016968388     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390.2017.1306893     Document Type: Article

References (38)

1. Arnida A, Janat-Amsbury MM, Ray A, Peterson CM, Ghandehari H., 2011. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 77:417–23.
2. Berry JP, Arnoux B, Stanislas G, Galle P, Chretien J., 1977. A microanalytic study of particles transport across the alveoli:role of blood platelets. Biomedicine 27:354–7.
3. Bockmann J, Lahl H, Eckert T, Unterhalt B., 2000. Blood titanium levels before and after oral administration titanium dioxide. Pharmazie 55:140–3.
4. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, et al. 2007. Renal clearance of quantum dots. Nat Biotechnol 25:1165–70.
5. Devarajan PV, Jindal AB, Patil RR, Mulla F, Gaikwad RV, Samad A., 2010. Particle shape:a new design parameter for passive targeting in splenotropic drug delivery. J Pharm Sci 99:2576–81.
6. Disdier C, Devoy J, Cosnefroy A, Chalansonnet M, Herlin-Boime N, Brun E, et al. 2015. Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood–brain barrier clearance and brain inflammation in rat. Part Fibre Toxicol 12:27.
7. Florence AT, Sakthivel T, Toth I., 2000. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J Control Release 65:253–9.
8. Geiser M, Quaile O, Wenk A, Wigge C, Eigeldinger-Berthou S, Hirn S, et al. 2013. Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol 10:19.
9. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555–60.
10. Geiser M, Stoeger T, Casaulta M, Chen S, Semmler-Behnke M, Bolle I, et al. 2014. Biokinetics of nanoparticles and susceptibility to particulate exposure in a murine model of cystic fibrosis. Part Fibre Toxicol 11:19.
11. Geraets L, Oomen AG, Krystek P, Jacobsen NR, Wallin H, Laurentie M, et al. 2014. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Part Fibre Toxicol 11:30.
12. 2 nanopowder as a tool for sensitive nanoparticle detection in complex matrices. J Nanopart Res 17:1–12.
13. Hillery AM, Jani PU, Florence AT., 1994. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J Drug Target 2:151–6.
14. Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schaffler M, et al. 2011. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 77:407–16.
15. Howe SE, Lickteig DJ, Plunkett KN, Ryerse JS, Konjufca V., 2014. The uptake of soluble and particulate antigens by epithelial cells in the mouse small intestine. PLoS One 9:e86656.
16. Hussain N, Florence AT., 1998. Utilizing bacterial mechanisms of epithelial cell entry:invasin-induced oral uptake of latex nanoparticles. Pharm Res 15:153–6.
17. Jani PU, McCarthy DE, Florence AT., 1994a. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharm 105:157–68.
18. Jani PU, McCarthy DE, Florence AT., 1994b. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administration. Int J Pharm 105:157–68.
19. Jones K, Morton J, Smith I, Jurkschat K, Harding AH, Evans G., 2015. Human in vivo and in vitro studies on gastrointestinal absorption of titanium dioxide nanoparticles. Toxicol Lett 233:95–101.
20. Kreyling WG, Biswas P, Messing ME, Gibson N, Geiser M, Wenk A, et al. 2011. Generation and characterization of stable, highly concentrated titanium dioxide nanoparticle aerosols for rodent inhalation studies. J Nanopart Res 13:511–24.
21. Kreyling WG, Hirn S, Moller W, Schleh C, Wenk A, Celik G, et al. 2014. Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano 8:222–33.
22. Kreyling WG, Holzwarth U, Haberl N, Kozempel J, Wenk A, Hirn S, et al. 2017. Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats (Part 1). Nanotoxicology. [Epub ahead of print]. doi:10.1080/17435390.2017.1306892
23. Lomer MC, Hutchinson C, Volkert S, Greenfield SM, Catterall A, Thompson RP, Powell JJ., 2004. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br J Nutr 92:947–55.
24. MacNicoll A, Kelly M, Aksoy H, Kramer E, Bouwmeester H, Chaudhry Q., 2015. A study of the uptake and biodistribution of nano-titanium dioxide using in vitro and in vivo models of oral intake. J Nanopart Res 17:1–20.
25. Oeff K, Konig A., 1955. Blood volume of rat organs and residual amount of blood after blood letting or irrigation; determination with radiophosphorus-labeled erythrocytes. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 226:98–102.
26. Pele LC, Thoree V, Bruggraber SF, Koller D, Thompson RP, Lomer MC, Powell JJ., 2015. Pharmaceutical/food grade titanium dioxide particles are absorbed into the bloodstream of human volunteers. Part Fibre Toxicol 12:26.
27. Peters RJ, Van Bemmel G, Herrera-Rivera Z, Helsper JP, Marvin HJ, Weigel S, et al. 2014. Characterisation of titanium dioxide nanoparticles in food products:analytical methods to define nanoparticles. J Agric Food Chem 62:6285–93.
28. Powell JJ, Ainley CC, Harvey RS, Mason IM, Kendall MD, Sankey EA, et al. 1996. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 38:390–5.
29. Powell JJ, Faria N, Thomas-Mckay E, Pele LC., 2010. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun 34:J226–33.
30. Schäffler M, Sousa F, Wenk A, Sitia L, Hirn S, Schleh C, et al. 2014. Blood protein coating of gold nanoparticles as potential tool for organ targeting. Biomaterials 35:3455–66.
31. Schleh C, Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schaffler M, et al. 2012. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 6:36–46.
32. Shi H, Magaye R, Castranova V, Zhao J., 2013. Titanium dioxide nanoparticles:a review of current toxicological data. Part Fibre Toxicol 10:15.
33. Sonavane G, Tomoda K, Makino K., 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration:effect of particle size. Colloids Surf B Biointerfaces 66:274–80.
34. Suh H, Jeong B, Liu F, Kim SW., 1998. Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells. Pharm Res 15:1495–8.
35. Tassinari R, Cubadda F, Moracci G, Aureli F, D’amato M, Valeri M, et al. 2014. Oral, short-term exposure to titanium dioxide nanoparticles in Sprague-Dawley rat:focus on reproductive and endocrine systems and spleen. Nanotoxicology 8:654–62.
36. Vaijayanthimala V, Tzeng YK, Chang HC, Li CL., 2009. The biocompatibility of fluorescent nanodiamonds and their mechanism of cellular uptake. Nanotechnology 20:425103.
37. Weir A, Westerhoff P, Fabricius L, Hristovski K, Von Goetz N., 2012. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 46:2242–50.
38. Zhang S, Chen X, Gu C, Zhang Y, Xu J, Bian Z, et al. 2009. The effect of iron oxide magnetic nanoparticles on smooth muscle cells. Nanoscale Res Lett 4:70–7.